Skip to main content
Screener/Healthcare/Biotechnology

ROIV — Roivant Sciences Ltd.

NASDAQ
$38.93+2.29 (+6.27%)
Large CapUnder $50Healthcare
$19.79
$42.50
$36.62
$39.08
EPS (TTM)$-1.10
P/E Ratio-23.91
Dividend Yield—
Market Cap$26.45B
Volume8.15M
Prev Close$36.62
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$2.0M-$265.9M$-0.3865.0%-13301.2%
Q3 '26$2.0M-$313.7M$-0.38—-15692.9%
Q2 '26$1.6M-$166.0M$-0.17—-10569.0%
Q2 '25$1.6M-$113.5M$-0.1792.9%-7225.9%
Q1 '25$2.2M-$223.4M$-0.3392.9%-10292.9%
Q1 '26$2.2M-$273.9M$-0.33—-12622.6%
Q4 '24$7.6M-$206.5M$-0.2997.3%-2727.5%
Q4 '25$7.6M-$252.4M$-0.29—-3333.9%
Get Your Daily Market Recap